Sign Up to like & get recommendations! 0
Published in 2017 at "Cochrane Database of Systematic Reviews"
DOI: 10.1002/14651858.cd010466.pub2
Abstract: Reason for withdrawal from publication The protocol is out of date and does not meet the current methodological standards of Cochrane. read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Saudi Journal of Ophthalmology"
DOI: 10.1016/j.sjopt.2019.04.001
Abstract: Objective The purpose of this paper is to review the efficacy and safety profile in children treated with topical 0.03% Tacrolimus ointment for vernal keratoconjunctivitis in Middle East and to propose a treatment posology. According… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Ocular Immunology and Inflammation"
DOI: 10.1080/09273948.2018.1467465
Abstract: ABSTRACT Purpose: The aim of the present prospective study was to evaluate the lacrimal fluid concentration of HMGB1 in young patients affected by Vernal Keratoconjunctivitis (VKC) compared to a control group of healthy subjects of… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Ocular immunology and inflammation"
DOI: 10.1080/09273948.2020.1745243
Abstract: Purpose: To compare corneal morphologic changes in vernal keratoconjunctivitis (VKC) patients before and after treatment with topical cyclosporin (CsA).Methods: 23 VKC patients and 40 healthy subjects as controls were considered. All patients were treated with… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Ocular immunology and inflammation"
DOI: 10.1080/09273948.2021.1891442
Abstract: Introduction: This case report describes an 8 year old boy unsuccessfully treated for years for Vernal Keratoconjunctivitis. Case report: We report a VKC resistant to all types of treatment known in the literature, such as… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Ocular immunology and inflammation"
DOI: 10.1080/09273948.2022.2103833
Abstract: Vernal keratoconjunctivitis (VKC) is a severe form of ocular allergy that compromises the quality of life of affected patients. Topical cyclosporine 0.1% cationic emulsion (CsA-CE) has been recently authorized for the treatment of severe VKC.… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Expert Opinion on Orphan Drugs"
DOI: 10.1080/21678707.2017.1300524
Abstract: ABSTRACT Introduction: Vernal keratoconjunctivitis (VKC) is a rare, chronic allergic disease affecting children in prepuberal age. The hallmark of VKC is the presence of conjunctival upper tarsal and/or limbal papillary reaction. Recurrences of inflammation are… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Cornea"
DOI: 10.1097/ico.0000000000001963
Abstract: PURPOSE To describe the clinical features, risk factors, and treatment outcomes after supratarsal injection of triamcinolone for vernal keratoconjunctivitis (VKC). METHODS A retrospective review of all patients treated with supratarsal triamcinolone for VKC between February… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Cornea"
DOI: 10.1097/ico.0000000000002553
Abstract: PURPOSE Severe vernal keratoconjunctivitis (VKC) can cause ocular surface disease including partial or complete limbal stem cell deficiency (LSCD), especially in early-onset and severe limbal form of VKC. We report a novel technique of doughnut… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.17824
Abstract: A 23-year-old male presented with three months of worsening blepharoconjunctivitis and dermatitis on his eyelids with a background of at least five years of allergic conjunctivitis (Figure 1). The patient was taking tralokinumab for three… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Pediatric Allergy and Immunology"
DOI: 10.1111/pai.12737
Abstract: We report the cases of 4 children affected by Vernal keratoconjunctivitis (VKC) treated with Omalizumab with resolution of ocular signs and symptoms. Vernal keratoconjunctivitis (VKC) is a chronic conjunctivitis, not responding to topical antihistamines and… read more here.